Department of Neurology, Thomas Jefferson University, Philadelphia, PA, United States.
Front Immunol. 2018 Nov 13;9:2562. doi: 10.3389/fimmu.2018.02562. eCollection 2018.
Interleukin-27 (IL-27) plays an important role in regulation of anti-inflammatory responses and autoimmunity; however, the molecular mechanisms of IL-27 in modulation of immune tolerance and autoimmunity have not been fully elucidated. Dendritic cells (DCs) play a central role in regulating immune responses mediated by innate and adaptive immune systems, but regulatory mechanisms of DCs in CD4 T cell-mediated immune responses have not yet been elucidated. Here we show that IL-27 treated mature DCs induced by LPS inhibit immune tolerance mediated by LPS-stimulated DCs. IL-27 treatment facilitates development of the CD4 CD1273G11 regulatory T cell subset and . By contrast, IL-27 treated immature DCs fail to modulate development of the CD4CD1273G11 regulatory T cell sub-population and . Our results suggest that IL-27 may break immune tolerance induced by LPS-stimulated mature DCs through modulating development of a specific CD4 regulatory T cell subset mediated by 3G11 and CD127. Our data reveal a new cellular regulatory mechanism of IL-27 that targets DC-mediated immune responses in autoimmune diseases such as multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE).
白细胞介素 27(IL-27)在调节抗炎反应和自身免疫中发挥重要作用;然而,IL-27 调节免疫耐受和自身免疫的分子机制尚未完全阐明。树突状细胞(DCs)在调节固有和适应性免疫系统介导的免疫反应中发挥核心作用,但 DCs 在 CD4 T 细胞介导的免疫反应中的调节机制尚未阐明。在这里,我们表明 LPS 诱导的成熟 DCs 经 IL-27 处理可抑制 LPS 刺激的 DCs 介导的免疫耐受。IL-27 处理促进了 CD4 CD1273G11 调节性 T 细胞亚群的发育。相比之下,IL-27 处理的未成熟 DCs 无法调节 CD4CD1273G11 调节性 T 细胞亚群的发育。我们的结果表明,IL-27 可能通过调节 3G11 和 CD127 介导的特定 CD4 调节性 T 细胞亚群的发育,打破 LPS 刺激的成熟 DCs 诱导的免疫耐受。我们的数据揭示了 IL-27 靶向 DC 介导的自身免疫性疾病(如多发性硬化症(MS)和实验性自身免疫性脑脊髓炎(EAE))中免疫反应的新细胞调节机制。